BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 21510825)

  • 1. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.
    Arulkumaran N; Unwin RJ; Tam FW
    Expert Opin Investig Drugs; 2011 Jul; 20(7):897-915. PubMed ID: 21510825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptor antagonists: a patent review (2010-2015).
    Park JH; Kim YC
    Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patent review of P2X7 receptor antagonists to treat inflammatory diseases (2018-present).
    Iqbal J; Bano S; Khan IA; Huang Q
    Expert Opin Ther Pat; 2024 Apr; 34(4):263-271. PubMed ID: 38828613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of inflammasome blockers as anti-inflammatory drugs.
    López-Castejón G; Pelegrín P
    Expert Opin Investig Drugs; 2012 Jul; 21(7):995-1007. PubMed ID: 22612568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2X7 receptor: A main player in inflammation.
    Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
    Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain.
    Alves LA; Bezerra RJ; Faria RX; Ferreira LG; da Silva Frutuoso V
    Molecules; 2013 Sep; 18(9):10953-72. PubMed ID: 24013409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
    Baudelet D; Lipka E; Millet R; Ghinet A
    Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.
    Burnstock G; Knight GE
    Purinergic Signal; 2018 Mar; 14(1):1-18. PubMed ID: 29164451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in postoperative ileus.
    Kimura H; Yamazaki T; Mihara T; Kaji N; Kishi K; Hori M
    J Vet Med Sci; 2022 Apr; 84(4):610-617. PubMed ID: 35249909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response.
    Faria RX; de Jesus Hiller N; Salles JP; Resende JALC; Diogo RT; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; de Luna Martins D
    J Bioenerg Biomembr; 2019 Aug; 51(4):277-290. PubMed ID: 31256283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of P2X7R in neuroinflammation and implications in Alzheimer's disease.
    Chen YH; Lin RR; Tao QQ
    Life Sci; 2021 Apr; 271():119187. PubMed ID: 33577858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.
    El Idrissi IG; Podlewska S; Abate C; Bojarski AJ; Lacivita E; Leopoldo M
    Curr Med Chem; 2024; 31(11):1361-1403. PubMed ID: 37013427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine.
    Gubert C; Fries GR; Pfaffenseller B; Ferrari P; Coutinho-Silva R; Morrone FB; Kapczinski F; Battastini AMO
    Mol Neurobiol; 2016 Jan; 53(1):611-620. PubMed ID: 25502294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic P2X7 receptor as a potential therapeutic target in depression.
    Qi W; Jin X; Guan W
    Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P2X7 receptor contributes to seizures and inflammation-driven long-lasting brain hyperexcitability following hypoxia in neonatal mice.
    Smith J; Menéndez Méndez A; Alves M; Parras A; Conte G; Bhattacharya A; Ceusters M; Nicke A; Henshall DC; Jimenez-Mateos EM; Engel T
    Br J Pharmacol; 2023 Jul; 180(13):1710-1729. PubMed ID: 36637008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.
    Gil B; Smith J; Tang Y; Illes P; Engel T
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus.
    Chu K; Yin B; Wang J; Peng G; Liang H; Xu Z; Du Y; Fang M; Xia Q; Luo B
    J Neuroinflammation; 2012 Apr; 9():69. PubMed ID: 22513224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
    Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
    Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
    Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
    J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic Receptors in Thrombosis and Inflammation.
    Hechler B; Gachet C
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.